Fed. Circ. Clarifies MedImmune Decision
A federal appeals court ruled Friday that marking products with their applicable patents does not create enough "controversy" under Article III of the U.S. Constitution to sustain a declaratory judgment suit,...To view the full article, register now.
Already a subscriber? Click here to view full article